SEVITERONEL VT-464 NO FURTHER A MYSTERY

Due to deficiency of molecular focused therapies available for these patients, as well as their intrinsic insensitivity to radiation therapy (two), You will find a clinical require for the development of new radiosensitization methods.Seviteronel (developmental codes VT-464 and, formerly, INO-464) is really an experimental cancer medication that is